Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-6599

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-6599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906599)

Label Image (Lbl500906599)
Venlafaxine Hydrochloride 75 mg extended-release capsules in a white bottle label from A-S Medication Solutions. The label includes dosage form and strength, storage instructions to keep at 68 to 77 degrees Fahrenheit, and package size of 90 capsules. The label features NDC number 50090-6599-0 and manufacturer information.*
FDA Label Image

Figure (Venlafaxine Fig1)

Figure (Venlafaxine Fig1)
A chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its ODV metabolite across various special populations, including hepatic impairment, renal impairment, CYP2D6 metabolizer status, age over 60, and gender. The x-axis represents change relative to reference value, ranging from 0 to 3.5.*
FDA Label Image

Figure (Venlafaxine Fig2)

Figure (Venlafaxine Fig2)
A scatter plot chart depicting the fold change and 90% confidence intervals (CI) of venlafaxine analyte measurements (Cmax and AUC) in the presence of various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis shows change relative to a reference value, ranging from 0 to 3 fold. Each drug interaction is represented by multiple points illustrating the pharmacokinetic effect on venlafaxine capsules extended release 75 mg.*
FDA Label Image

Figure (Venlafaxine Fig3)

Figure (Venlafaxine Fig3)
A chart displaying the pharmacokinetic (PK) fold change and 90% confidence intervals for various analytes of interacting drugs relative to a reference value. The drugs listed include Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium, with their respective analytes and PK parameters (Cmax and AUC) plotted along the x-axis representing fold change values from 0 to 3.*
FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical Structure (Venlafaxine Str)
Chemical structure of venlafaxine hydrochloride, showing its molecular arrangement including a cyclohexane ring, a methoxy-substituted aromatic ring, and a nitrogen-containing side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.